Co-Inventors
Bennuru, Sasi
Lustigman, Sara
Abraham, David
Applications
Vaccines
Therapeutics
Diagnostics
Therapeutic Areas
Rare/Neglected Diseases
Ophthalmology
Infectious Disease
Dermatology
Research Products
Plasmids/Vectors
Antibodies
The technology outlined in the document is focused on the discovery of novel biomarkers for Onchocerciasis, a parasitic disease also known as river blindness, which is transmitted by blackfly vectors. The document describes the identification of the first Onchocerca volvulus-encoded molecules that are adult-specific and can be used as markers for macrofilaricidal activity, which is the ability to kill adult worms. Using advanced methods such as proteomics, comparative transcriptomics, and genomics, the researchers have identified 14 biomarkers that are indicative of viable adult worms and can be used in assays to detect active infections. These antigens are highly specific to Onchocerca volvulus and do not have homology to other filariae or to humans or mice, which could potentially lead to more targeted and effective treatments for onchocerciasis.
Commercial Applications
The discovery of specific biomarkers for Onchocerciasis has wide-reaching potential applications, including the development of precise diagnostic assays that could revolutionize the monitoring and treatment of the disease. These biomarkers enable the creation of tests to measure the efficacy of drug treatments by detecting the presence of adult Onchocerca volvulus worms, thereby informing elimination strategies. Moreover, they may aid in vaccine research by identifying immune responses that correlate with protection, and in public health, where they could be used to map disease prevalence and intensity, optimizing resource allocation for intervention programs.
Competitive Advantages
The technology presents a significant advance in the fight against Onchocerciasis by offering highly specific biomarkers for detecting active infections, which are crucial for accurate diagnosis and monitoring of the disease. This specificity confers a considerable advantage over existing diagnostic methods, potentially reducing false positives and enhancing the effectiveness of eradication programs. With its innovative approach to identifying adult worms of Onchocerca volvulus, this technology promises to be a valuable tool in the global effort to eliminate a disease that affects millions in resource-limited communities.
